Get started
Author

Sergey Izmailyan

ORCID: 0000-0001-9589-7399
Observed ORCID: 0000-0001-9589-7399
OpenAlex ID: A5084528915
Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population
2021 · Simon C. Mathews, Sergey Izmailyan, et al. · Clinical Gastroenterology and Hepatology · 53
Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline
2018 · Joseph V. Newman, Jian Zhou, et al. · Antimicrobial Agents and Chemotherapy · 45
PDF
Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 Studies
2020 · Vanessa Grant-Di Felice, Ekaterina Efimova, et al. · Surgical Infections · 29
Eravacycline: A New Treatment Option for Complicated Intra-Abdominal Infections in the Age of Multidrug Resistance
2019 · Joseph S Solomkin, Angie Sway, et al. · Future Microbiology · 21
Mass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy Subjects
2018 · Joseph V. Newman, Jian Zhou, et al. · Antimicrobial Agents and Chemotherapy · 20
Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical Trials
2020 · Tomefa E Asempa, Sergey Izmailyan, et al. · Open Forum Infectious Diseases · 11
PDF
An Evaluation of Treatment Patterns and Associated Outcomes Among Adult Hospitalized Patients With Lower-Risk Community-Acquired Complicated Intra-abdominal Infections: How Often Are Expert Guidelines Followed?
2020 · Thomas P Lodise, Sergey Izmailyan, et al. · Open Forum Infectious Diseases · 11
PDF
1978. Efficacy of Eravacycline in Secondary Bacteremia: A Post Hoc Analysis of Two Phase 3 studies of Complicated Intra-Abdominal Infection
2018 · Kenneth Lawrence, Melanie Olesky, et al. · Open Forum Infectious Diseases · 7
TOP-251 Efficacy and safety of Bemnifosbuvir and Ruzasvir after 8 weeks of treatment in patients with chronic hepatitis C virus (HCV) infection
2025 · Alina Jucov, Saeed Sadiq Hamid, et al. · Journal of Hepatology · 4
1963. Combined Microbiological Response Rates From Two Phase 3 Trials Demonstrating the Activity of Eravacycline in the Treatment of Complicated Intra-abdominal Infections: A Pooled Analysis of IGNITE1 and IGNITE4
2018 · Joseph Newman, Sergey Izmailyan, et al. · Open Forum Infectious Diseases · 4
PDF
THU-382 Lead-in cohort results from a phase 2 study of a novel 8-week combination regimen of Bemnifosbuvir and Ruzasvir in patients with chronic hepatitis C virus infection
2024 · Alina Jucov, Brian Conway, et al. · Journal of Hepatology · 3
1976. Pooled Analysis of Safety Data From Phases 2 and 3 Clinical Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections
2018 · Ekaterina Efimova, Melanie Olesky, et al. · Open Forum Infectious Diseases · 3
652: Eravacycline Is Effective in High-risk Complicated Intra-abdominal Infection Subgroups
2018 · Kristen Ditch, Kenneth Lawrence, et al. · Critical Care Medicine · 1
Integrated Population Pharmacokinetic Model of Bemnifosbuvir and Metabolites
2025 · Christine Neumar, Liaoliao Li, et al. · American Conference on Pharmacometrics (ACoP)
PDF
2264. An Evaluation of Empiric Treatment Patterns for Adult Patients with Community-Onset (CO) “Low-Risk” (LR) Complicated Intra-Abdominal Infections (cIAI) Across US Hospitals
2019 · Thomas Lodise, Sergey Izmailyan, et al. · Open Forum Infectious Diseases
Works count: 15
Citation count: 212
H-index: 7
I10-index: 7
Year
Topic
Type